Pfizer requests amended EUA to allow COVID-19 boosters for all U.S. adults
Pfizer yesterday asked the Food and Drug Administration to amend the emergency use authorization for its COVID-19 vaccine to allow all individuals age 18 and older to receive booster shots. In its request, Pfizer cited data from its ongoing phase 3 clinical trial that confirm the efficacy and safety of a third, 30-microgram dose of the vaccine.
Related News Articles
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…